Bingerbruck, Germany

John F Quirke

This inventor holds 4 USPTO granted patents. Top assignee: Boehringer Ingelheim Vetmedica Gmbh. Active years: 1993-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John F Quirke. Retrieved from https://idiyas.com/inventor/john-f-quirke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1993-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of John F Quirke

Introduction

John F Quirke is a notable inventor based in Bingerbruck, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the separation of enantiomers. With a total of 4 patents to his name, Quirke's work has had a meaningful impact on both veterinary medicine and animal feeds.

Latest Patents

Quirke's latest patents focus on the separation of enantiomers of cimaterol, specifically (-)-cimaterol. The inventions relate to the processes for preparing these enantiomers and their use in pharmaceutical compositions and animal feeds. This innovative approach enhances the efficacy of cimaterol in various applications.

Career Highlights

Quirke is associated with Boehringer Ingelheim Vetmedica GmbH, a leading company in veterinary pharmaceuticals. His work at this organization has allowed him to explore and develop new methods for improving animal health through innovative drug formulations.

Collaborations

Throughout his career, Quirke has collaborated with esteemed colleagues such as Wolfgang Resemann and Adolf Durr. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

John F Quirke's contributions to the field of pharmaceuticals, particularly through his patents on cimaterol, demonstrate his commitment to innovation and improving animal health. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…